Novartis Investigative Site

Durban, KwaZulu-Natal 4052

0 studies enrolling now · 4 studies all time

What they study most

Acute Heart Failure, Atherosclerosis, Chronic Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction

Studies at this site

• Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction — Completed
• Global Non-interventional Heart Failure Disease Registry — Stopped early